ApprovalTrail

Drug · DIN 02428385

BISMUTH

No: cancelled before it was sold

Authorized, then cancelled before it was ever sold in Canada.

Status Cancelled Pre Market since July 15, 2019.
Drug Identification Number (DIN)
02428385
Company (DIN owner)
Actavis Pharma CompanyToronto, Ontario, Canada
Schedule
Non-prescription drugs
Dosage form
Suspension
Route
Oral
Therapeutic class (ATC)
Bismuth preparations A07BB
Class
Human
Record last updated
June 23, 2026

Active ingredients

As listed in the Drug Product Database.

IngredientStrengthPer
BISMUTH SUBSALICYLATE17.5 MGML

Other DINs named BISMUTH